查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1134517

東莨菪鹼的全球市場:現狀分析與預測(2022年～2028年)

Scopolamine Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 154 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球東莨菪鹼的市場規模，2020年將達到4億美元以上，在預測期間(2022年～2028年)時預計將以約5％的年複合成長率。世界範圍內越來越多的旅行者、越來越多的暈車患者以及更多因慢性病而進行的手術正在推動東莨菪鹼市場的增長。

本報告提供全球東莨菪鹼市場的相關調查，提供市場洞察，市場趨勢，競爭模式，企業概要等全面性資訊。

目錄

第1章 市場簡介

  • 市場定義
  • 主要目的
  • 相關利益者
  • 限制

第2章 調查方法或假設

  • 東莨菪鹼市場調查流程
  • 東莨菪鹼市場調查手法
  • 受訪者簡介

第3章 市場摘要

第4章 摘要整理

第5章 東莨菪鹼市場的COVID-19影響

第6章 東莨菪鹼市場收益(2020年～2028年)

第7章 市場洞察:各劑型

  • 注射劑
  • 錠劑
  • 經皮吸收貼片
  • 其他

第8章 市場洞察:各流通管道

  • 醫院藥局
  • 零售藥局
  • 其他

第9章 市場洞察:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他的北美
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他的亞太地區
  • 全球其他地區

第10章 東莨菪鹼市場動態

  • 推動市場要素
  • 市場課題
  • 影響分析

第11章 東莨菪鹼市場機會

第12章 東莨菪鹼市場趨勢

第13章 需求面和供給面的分析

  • 需求面分析
  • 供給面分析

第14章 價值鏈分析

第15章 競爭模式

  • 競爭情形
    • 波特的五力分析

第16章 公司概要

  • Pfizer Inc.
  • Baxter International Inc.
  • Myungmoon Pharm Co Ltd
  • Novartis AG
  • Perrigo Company PLC
  • Fine Chemicals Corporation
  • GSK plc
  • Alchem International Pvt. Ltd.
  • Phytex Australia Pty Ltd
  • Caleb Pharmaceuticals, Inc.

第17章 免責聲明

簡介目錄
Product Code: UMHE211161

Global Scopolamine Market was valued at more than USD 400 million in 2020 and is expected to grow at a significant rate of around 5% during the forecast period. The global scopolamine market is anticipated to witness an uptick owing to the rising number of people having motion sickness, and growing awareness among the population globally. About 1 in 3 people are considered highly susceptible to motion sickness. Furthermore, American Institute of Stress, 80% of U.S. workers said that they experience stress on the job. Also, Over three-quarters of adult report symptoms of stress, including headache, tiredness, or sleeping problems, as per the American Psychological Association, 2019. This rising number of people having psychological stress is also one of the prominent factors due to which people feel motion sickness which in turn is also increasing the demand for scopolamine drugs among the population. In addition to this, the growing number of travelers across the globe and an increasing number of surgeries due to chronic diseases are also some of the factors contributing to the growth of the market.

Pfizer Inc., Baxter International Inc., Myungmoon Pharm Co Ltd., Novartis AG, Perrigo Company PLC, Fine Chemicals Corporation, GSK plc, Alchem International Pvt. Ltd., Phytex Australia Pty Ltd., Caleb Pharmaceuticals, Inc. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with scopolamine.

 

Insights Presented in the Report:

"Amongst dosage form, transdermal patches category to witness higher CAGR during the forecast period"

Based on dosage form, the scopolamine market is segmented into injectables, tablets, transdermal patches, and others. The transdermal patches scopolamine segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe as they are widely for the treatment of motion sickness nowadays. Furthermore, growth in the number of domestic and international travelers and in areas of product launches in the market is also positively influencing the growth of the market.

"Amongst distribution channel, the hospital pharmacies to hold a significant share in the market in 2020"

On the basis of distribution channels, the market is fragmented into hospital pharmacies, retail pharmacies, and others. Among these, the hospital pharmacies to hold a significant share in the market in 2020. This is mainly due to the increasing preference of the patients to avail treatment in hospitals and the easy availability of the medication in hospital pharmacies. However, the online pharmacy segment is expected to witness significant growth owing to the growing penetration of e-pharmacy platforms across the world coupled with increasing awareness regarding services offered by e-pharmacy.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the All-Terrain Vehicle industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure, a rising number of surgeries, and an increasing number of travelers in the region. For instance, U.S. domestic travel increased 1.7% in 2019 to a total of 2.3 billion person-trips. Also, Leisure travel accounted for 80% of all U.S. domestic travel in 2019. Furthermore, the presence of key industry players in the region and an increasing number of product launches are also some of the factors contributing to the market growth.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global scopolamine market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Scopolamine Market
  • 2.2. Research Methodology of the Scopolamine Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE SCOPOLAMINE MARKET

6 SCOPOLAMINE MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY DOSAGE FORM

  • 7.1. Injectables
  • 7.2. Tablets
  • 7.3. Transdermal Patches
  • 7.4. Others

8 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

  • 8.1. Hospital Pharmacies
  • 8.2. Retail Pharmacies
  • 8.3. Others

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 SCOPOLAMINE MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 SCOPOLAMINE MARKET OPPORTUNITIES

12 SCOPOLAMINE MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. Pfizer Inc.
  • 16.2. Baxter International Inc.
  • 16.3. Myungmoon Pharm Co Ltd
  • 16.4. Novartis AG
  • 16.5. Perrigo Company PLC
  • 16.6. Fine Chemicals Corporation
  • 16.7. GSK plc
  • 16.8. Alchem International Pvt. Ltd.
  • 16.9. Phytex Australia Pty Ltd
  • 16.10. Caleb Pharmaceuticals, Inc.

17 DISCLAIMER